Skip to main content
Top
Published in: Supportive Care in Cancer 10/2018

01-10-2018 | Commentary

Clinicians’ perceptions of medication errors with opioids in cancer and palliative care services: a priority setting report

Authors: N. Heneka, T. Shaw, C. Azzi, J. L. Phillips

Published in: Supportive Care in Cancer | Issue 10/2018

Login to get access

Abstract

This paper reports the findings of a priority setting process, undertaken with cancer and palliative care clinicians, to better understand the characteristics of medication errors with opioids within their services. Participants representing six public hospitals in one Australian state took part in a series of priority setting workshops and, drawing on actual incidents occurring in their services, sought to identify where in the opioid medication process errors were most frequently occurring. Opioid error types and perceived contributing factors were explored, and strategies to reduce/prevent opioid errors were proposed. The priority setting process provided valuable insights into the types of opioid errors that occur in cancer and palliative care services and the complexity of addressing opioid errors from the clinician’s perspective. The findings from this priority setting process will inform future targeted quality improvement initiatives to support safe opioid medication practices in cancer and palliative care services.
Literature
5.
go back to reference Australian Institute of Health and Welfare (2014) Palliative care services in Australia. AIHW, cat. No. HWI 128. Canberra Australian Institute of Health and Welfare (2014) Palliative care services in Australia. AIHW, cat. No. HWI 128. Canberra
6.
go back to reference Myers SS, Lynn J (2001) Patients with eventually fatal chronic illness: their importance within a national research agenda on improving patient safety and reducing medical errors. J Palliat Med 4(3):325–332CrossRefPubMed Myers SS, Lynn J (2001) Patients with eventually fatal chronic illness: their importance within a national research agenda on improving patient safety and reducing medical errors. J Palliat Med 4(3):325–332CrossRefPubMed
8.
go back to reference Raijmakers NJ, van Zuylen L, Furst CJ, Beccaro M, Maiorana L, Pilastri P, Rossi C, Flego G, van der Heide A, Costantini M (2013) Variation in medication use in cancer patients at the end of life: a cross-sectional analysis. Support Care Cancer 21(4):1003–1011CrossRefPubMed Raijmakers NJ, van Zuylen L, Furst CJ, Beccaro M, Maiorana L, Pilastri P, Rossi C, Flego G, van der Heide A, Costantini M (2013) Variation in medication use in cancer patients at the end of life: a cross-sectional analysis. Support Care Cancer 21(4):1003–1011CrossRefPubMed
9.
go back to reference Currow DC, Stevenson JP, Abernethy AP, Plummer J, Shelby-James TM (2007) Prescribing in palliative care as death approaches. J Am Geriatr Soc 55(4):590–595CrossRefPubMed Currow DC, Stevenson JP, Abernethy AP, Plummer J, Shelby-James TM (2007) Prescribing in palliative care as death approaches. J Am Geriatr Soc 55(4):590–595CrossRefPubMed
11.
go back to reference Phillips JL, Heneka N, Hickman L, Lam L, Shaw T (2017) Can a complex online intervention improve cancer nurses’ pain screening and assessment practices? Results from a multicenter, pre-post test pilot study. Pain Manag Nurs 18(2):75–89CrossRefPubMed Phillips JL, Heneka N, Hickman L, Lam L, Shaw T (2017) Can a complex online intervention improve cancer nurses’ pain screening and assessment practices? Results from a multicenter, pre-post test pilot study. Pain Manag Nurs 18(2):75–89CrossRefPubMed
Metadata
Title
Clinicians’ perceptions of medication errors with opioids in cancer and palliative care services: a priority setting report
Authors
N. Heneka
T. Shaw
C. Azzi
J. L. Phillips
Publication date
01-10-2018
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 10/2018
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4231-0

Other articles of this Issue 10/2018

Supportive Care in Cancer 10/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine